Relx (RENX) Getting Somewhat Favorable Media Coverage, Study Finds

Press coverage about Relx (NYSE:RENX) has trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Relx earned a daily sentiment score of 0.22 on Accern’s scale. Accern also assigned news headlines about the technology company an impact score of 46.6527239352571 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Several equities research analysts have recently issued reports on the company. BidaskClub raised Relx from a “hold” rating to a “buy” rating in a research note on Thursday, September 7th. Zacks Investment Research raised Relx from a “hold” rating to a “buy” rating and set a $24.00 price objective for the company in a research note on Saturday, September 9th.

Relx (NYSE:RENX) traded up $0.11 during trading hours on Friday, hitting $23.14. The stock had a trading volume of 36,285 shares, compared to its average volume of 48,475. Relx has a 1-year low of $16.30 and a 1-year high of $23.30. The company has a debt-to-equity ratio of 2.35, a current ratio of 0.47 and a quick ratio of 0.43.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Transcript Daily and is the property of of Transcript Daily. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at

Relx Company Profile

RELX NV is a holding company, which holds interests in RELX Group plc. RELX Group is a global provider of information and analytics for professional and business customers across industries. The Company operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal, and Exhibitions.

Insider Buying and Selling by Quarter for Relx (NYSE:RENX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with's FREE daily email newsletter.

Leave a Reply